Vasaka

<h3> Absolute Contraindications of Vasaka </h3> <h4> Pregnancy (risk of uterine stimulation / fetal risk)</h4> <ul> <li> 🤰 <li> Recommendation: Avoid Vasaka (leaf extracts, teas, syrups, concentrated preparations) during pregnancy. If you are pregnant, do not self-administer Vasaka preparations; consult an obstetrician before any herbal use. <li> Reasoning: Several experimental and toxicology reviews report oxytocic/uterotonic activity for vasicine and related alkaloids and note accumulation of vasicine in uterine tissue in animal models; therefore systemic use in pregnancy could risk uterine stimulation. <li> Scientific_Study_Title: Adhatoda vasica: a critical review of ethnopharmacological and toxicological data <li> Scientific_Study_Authors: U P Claeson, T Malmfors, G Wikman, J G Bruhn <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/10967448/ <li> Scientific_Study_Excerpt: <p>This peer-reviewed critical review summarizes pharmacological and toxicological data for Adhatoda vasica, noting multiple scientific reports over the previous decades that describe oxytocic and abortifacient effects of vasicine and related alkaloids in experimental models. The authors evaluate historical and experimental studies and highlight the repeated observations that certain alkaloid fractions show uterine stimulant properties in animals. While the review emphasises gaps and variability in human data, it concludes that the documented oxytocic findings raise safety concerns for systemic use during pregnancy and recommend avoidance or clinical oversight where relevant.</p> <p>The review is widely cited in safety assessments and remains a core reference when clinicians advise against use of concentrated Adhatoda preparations during pregnancy because of the plausible risk of uterine stimulation.</p> </ul> <h4> Concurrent use with anticoagulant / antiplatelet drugs (e.g., warfarin, dabigatran, aspirin)</h4> <ul> <li> ⚠️🩸 <li> Recommendation: Do not take Vasaka leaf extracts or concentrated preparations at the same time as prescribed anticoagulant or antiplatelet medications without physician supervision; consider avoiding concurrent use. <li> Reasoning: Controlled experimental work shows Vasaka leaf extract can shorten bleeding time and increase platelet aggregation in vitro and in animal models - potentially opposing anticoagulant therapy and unpredictably altering bleeding/thrombosis risk. <li> Scientific_Study_Title: Effect Of Justicia Adhatoda (Malabar Nut) Leaf Extract On Drug-Induced Coagulopathy In Mice And In-Vitro Platelet Aggregation Of Human Blood <li> Scientific_Study_Authors: Sehrish Zaffar, Mahwash Malik, Abdul Mudabbir Rehan, Nazia Rashid, Sadia Chiragh, Kamran Zaman <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/33774945/ <li> Scientific_Study_Excerpt: <p>In this experimental study the authors administered Justicia adhatoda leaf extract in models where bleeding was pharmacologically induced (warfarin, aspirin, dabigatran). The extract reduced bleeding time in treated mice compared with controls and increased platelet aggregation in human blood in vitro in a dose-dependent way. Platelet counts rose in some treated groups. The investigators conclude the extract had haemostatic activity, likely via increased platelet aggregation, and that this property reversed drug-induced bleeding in the animal model. These findings suggest Vasaka can materially alter haemostasis when combined with anticoagulant or antiplatelet drugs.</p> <p>The study underpins clinical caution: patients on prescription blood thinners should not add Vasaka extracts without medical oversight because the herb may reduce drug effectiveness or cause unpredictable changes in clotting.</p> </ul> <h4> Concurrent use with anti-diabetic agents (risk of additive glucose-lowering)</h4> <ul> <li> 🍬 <li> Recommendation: If you are on prescription diabetes medicines (especially agents that lower post-meal glucose or insulin/sulfonylureas), avoid using Vasaka extracts without supervision-monitor blood glucose closely if used under medical advice. <li> Reasoning: In vitro enzyme studies show Vasaka leaf compounds inhibit intestinal carbohydrate-digesting enzymes (α-glucosidase/sucrase and α-amylase), which can lower post-prandial glucose; combining with antidiabetic drugs may increase hypoglycemia risk or require dose adjustment. <li> Scientific_Study_Title: Inhibitory effect on α-glucosidase by Adhatoda vasica Nees <li> Scientific_Study_Authors: Hong Gao, Yi-Na Huang, Bo Gao, Peng Li, Chika Inagaki, Jun Kawabata <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/26065759/ <li> Scientific_Study_Excerpt: <p>This experimental Food Chemistry study screened many plant extracts and isolated vasicine and vasicinol from Adhatoda vasica as active inhibitors of mammalian α-glucosidase (sucrase). Vasicine and vasicinol competitively inhibited sucrase with measurable Ki and IC50 values in enzyme assays, indicating potential to reduce post-meal glucose absorption. The authors propose a mechanistic basis for antidiabetic effects and suggest extracts or isolated compounds could alter glucose handling in vivo. While clinical human data are limited, the clear biochemical inhibition supports clinical caution when combining Vasaka with glucose-lowering drugs.</p> </ul> <h3> Relative Contraindications of Vasaka </h3> <h4> Breastfeeding (insufficient safety data)</h4> <ul> <li> 🤱 <li> Recommendation: Prefer to avoid systemic Vasaka extracts while breastfeeding unless supervised by a clinician; small amounts in culinary/herbal tea forms are less clear - discuss with your provider. <li> Reasoning: High-quality human data on Vasaka safety during lactation are limited. Because active alkaloids are absorbed systemically and appear in tissues, a conservative approach avoids concentrated preparations while breastfeeding. <li> Scientific_Study_Title: Adhatoda vasica: a critical review of ethnopharmacological and toxicological data <li> Scientific_Study_Authors: U P Claeson, T Malmfors, G Wikman, J G Bruhn <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/10967448/ <li> Scientific_Study_Excerpt: <p>The review compiles traditional uses and experimental toxicology information, noting a paucity of robust human safety data for special populations (pregnancy, lactation). While many traditional remedies include Vasaka, the authors highlight data gaps and recommend caution in situations where exposure of a developing infant is possible because alkaloids are systemically active and human lactation transfer studies are not available.</p> </ul> <h4> Pre-existing prothrombotic disorders (e.g., history of DVT, PE)</h4> <ul> <li> ⚠️ <li> Recommendation: Use with caution or avoid systemic Vasaka if you have a history of thrombosis or are at high thrombotic risk; discuss with a hematologist or your prescribing clinician. <li> Reasoning: Because Vasaka extracts increase platelet aggregation and shorten bleeding time in experimental settings, they could theoretically raise clotting risk in susceptible people. <li> Scientific_Study_Title: Effect Of Justicia Adhatoda (Malabar Nut) Leaf Extract On Drug-Induced Coagulopathy In Mice And In-Vitro Platelet Aggregation Of Human Blood <li> Scientific_Study_Authors: Sehrish Zaffar, Mahwash Malik, Abdul Mudabbir Rehan, Nazia Rashid, Sadia Chiragh, Kamran Zaman <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/33774945/ <li> Scientific_Study_Excerpt: <p>The study’s animal and in-vitro findings indicate leaf extract promotes platelet aggregation and reduces bleeding time in models of drug-induced coagulopathy. Given these haemostatic actions, individuals already prone to thrombosis may face increased clotting risk if exposed to concentrated Vasaka preparations-thus, clinical prudence is advised.</p> </ul>